🏥 治験ポータル
← 治験一覧に戻る

L-カルニチンは肝切除患者のアンモニア代謝を改善する

基本情報

NCT ID
NCT03021876
ステータス
不明
試験のフェーズ
第2/第3相
試験タイプ
介入
目標被験者数
80
治験依頼者名
Kochi University

概要

L-carnitine is synthesized from lysine and methionine. Postmortem concentrations of carnitine in liver, muscle, heart, kidney, and brain averaged only one-fourth to one-third those in corresponding tissues of eight normally nourished non-hepatic patients who died after an acute illness of a 1-3-day duration. In the recent years, it has been reported that sirtuin 3 (SIRT3) is protective against acute kidney injury (AKI) and suggest that enhancing SIRT3 to improve mitochondrial dynamics has potential as a strategy for improving outcomes of renal injury. In the current study, it is the first clinical interventional research whether L-carnitine corrects ammonia metabolism associated with liver injury in hepatectomized patients.

対象疾患

Ammonia Metabolism

介入

L-carnitine(DRUG)
usual intake(OTHER)

依頼者(Sponsor)

実施施設 (1)

高知県・高知市病院企業団立高知医療センター

Kochi, Kochi, Japan(RECRUITING)